Bixiye
QP43-22 Reminder: Medical Drug Coding for Botulinum Toxins
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Natiijooyinka Raadinta
Soo bandhiga 1411 - 1420 ee natiijooyinka 4296
Bixiye
QP44-22 Improved Provider Webpage
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Bixiye
QP45-22 First Responder Mental Health Summit: Clinician Awareness Course Friday, June 24
Taariikhda uu dhaqangalayo Barnaamijka: May 25, 2022
Bixiye
QP36-22 Commercial Pharmacy Benefit Exclusion for Xolair®
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP37-22 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: VoxzogoTM (vosoritide)
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP38-22 Updates to Authorization Request with Unlisted or Unspecified Codes
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
QP40-22 Temporary Rate Increase for Personal Care Attendant (PCA) Services
Taariikhda uu dhaqangalayo Barnaamijka: May 11, 2022
Bixiye
P29-22 2022 Renewal Changes Summary for Blue Plus Referral Health Professional Providers
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022
Bixiye
P25-22 Update: Modifier -52, -CO and -CQ Reimbursement Changes – Effective July 1, 2022
Taariikhda uu dhaqangalayo Barnaamijka: May 02, 2022